Xtant Medical Holdings, Inc. (XTNT) › Cost of RevenueXtant Medical Holdings, Inc. (XTNT) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2011: $9.11M2012: $10.34M2013: $14.19M2014: $13.03M2015: $20.26M2016: $27.71M2017: $32.51M2018: $28.72M2019: $22.17M2020: $18.95M2021: $22.77M2022: $25.83M2023: $35.84M2024: $49.05M2025: $49.65M$49.65M2011Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$49.65M+1.2%2024$49.05M+36.9%2023$35.84M+38.7%2022$25.83M+13.4%2021$22.77M+20.2%2020$18.95M-14.5%2019$22.17M-22.8%2018$28.72M-11.7%2017$32.51M+17.3%2016$27.71M+36.8%2015$20.26M+55.5%2014$13.03M-8.1%2013$14.19M+37.2%2012$10.34M+13.5%2011$9.11M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share